Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Yuki Sunagawa"'
Autor:
Yuki Sunagawa, Suguru Yamada, Fuminori Sonohara, Keisuke Kurimoto, Nobutake Tanaka, Yunosuke Suzuki, Yoshikuni Inokawa, Hideki Takami, Masamichi Hayashi, Mitsuro Kanda, Chie Tanaka, Goro Nakayama, Masahiko Koike, Yasuhiro Kodera
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Circular RNA (circRNA) is a type of non-coding RNA known to affect cancer-related micro RNAs and various transcription factors. circRNA has promise as a cancer-related biomarker because its circular structure affords high stability. We found
Externí odkaz:
https://doaj.org/article/f10be62b19494c76af33c843a3615951
Autor:
Fuminori Sonohara, Masahiko Koike, Hideki Takami, Yuki Sunagawa, Suguru Yamada, Goro Nakayama, Keisuke Kurimoto, Nobutake Tanaka, Masamichi Hayashi, Yasuhiro Kodera, Yunosuke Suzuki, Chie Tanaka, Yoshikuni Inokawa, Mitsuro Kanda
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports
Scientific Reports
Circular RNA (circRNA) is a type of non-coding RNA known to affect cancer-related micro RNAs and various transcription factors. circRNA has promise as a cancer-related biomarker because its circular structure affords high stability. We found using hi
Autor:
Masamichi Hayashi, Yasuhiro Kodera, Yuki Sunagawa, Suguru Yamada, Goro Nakayama, Nobuhiko Nakagawa, Fuminori Sonohara, Masahiko Koike, Raju Kandimalla, Yoshikuni Inokawa, Chie Tanaka, Mitsuro Kanda, Hideki Takami, Katsuhito Tanaka
Publikováno v:
Anticancer Research. 40:6665-6676
BACKGROUND/AIM N6-Methyladenosine (m6A), the most abundant internal modification of RNA, plays a critical role in cancer development. However, the clinical implications of m6A in hepatocellular carcinoma (HCC) remain unclear. MATERIALS AND METHODS We
Autor:
Chie Tanaka, Yuki Sunagawa, Yasuhiro Kodera, Hideki Takami, Masamichi Hayashi, Fuminori Sonohara, Masaya Suenaga, Suguru Yamada, Goro Nakayama, Michitaka Fujiwara, Mitsuro Kanda, Daisuke Kobayashi, S. Takeda, Mitsuru Tashiro, Masahiko Koike
Publikováno v:
Anticancer Research. 40:1843-1853
Background/aim Epithelial-to-mesenchymal transition (EMT) plays important roles in cancer progression. This study aimed to identify the exosomal miRNA (exo-miRNA) profiles related to the EMT status in pancreatic cancer (PC). Materials and methods Com
Autor:
Hiroshi Tanabe, Fuminori Sonohara, Yuki Sunagawa, Nobutake Tanaka, Chie Tanaka, Mitsuro Kanda, Yasuhiro Kodera, Masamichi Hayashi, Hideki Takami, Yoshikuni Inokawa, Keisuke Kurimoto, Masahiko Koike, Suguru Yamada, Goro Nakayama
Publikováno v:
Clinical Epigenetics
Background Pancreatic cancer is one of the lethal cancers among solid malignancies. Pathological diagnosis of surgical margins is sometimes unreliable due to tissue shrinkage, invisible field cancerization and skipped lesions like tumor budding. As a
Publikováno v:
JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE. 68:71-76
Autor:
Hideki Takami, Fuminori Sonohara, Yuki Sunagawa, Yasuhiro Kodera, Katsuhito Tanaka, Masahiko Koike, Masamichi Hayashi, Mitsuro Kanda, Suguru Yamada, Chie Tanaka, Yoshikuni Inokawa, Goro Nakayama, Nobuhiko Nakagawa
Publikováno v:
Oncology Letters
N6-methyladenosine (m6A), the most abundant internal RNA modification, serves a critical role in cancer development. However, the clinical implications of m6A in hepatocellular carcinoma (HCC) remain unclear. The present study sought to reveal the po
Autor:
Yuki Sunagawa, Masahiko Koike, Yoshiyasu Kato, Hideki Takami, Masamichi Hayashi, Yoshikuni Inokawa, Yasuhiro Kodera, Suguru Yamada, Goro Nakayama, Fuminori Sonohara
Publikováno v:
Journal of hepato-biliary-pancreatic sciencesREFERENCES. 28(1)
BACKGROUND This study aimed to evaluate the usefulness of perioperative indocyanine green elimination rate (ICG-K) as a predictive factor of posthepatectomy liver failure (PHLF). METHODS This study enrolled 193 patients who underwent hepatectomy betw
Autor:
Kazuhiro Ezaka, Kenta Murotani, Kazuhiko Nakata, Hideki Takami, Kiyoshi Ishigure, Mitsuro Kanda, Yuki Sunagawa, Hiroyuki Yokoyama, Yasuhiro Kodera, Takahiro Asada, Chie Tanaka, Takanori Matsui, Akiharu Ishiyama, Hiroshi Nakayama, Masahiko Koike, Shinichi Umeda, Michitaka Fujiwara, Ayako Mitsuma, Norifumi Hattori, Yuichi Ando, Daisuke Kobayashi, Suguru Yamada, Goro Nakayama, Tsutomu Fujii
Publikováno v:
The Oncologist. 23:919-927
Purpose The aim of this randomized, multicenter, noncomparative, phase II trial was to investigate the efficacy and safety of two potential first-line treatments, capecitabine and oxaliplatin (CapOX) plus bevacizumab (BEV) and capecitabine and irinot
Autor:
Haruyoshi Tanaka, Michitaka Fujiwara, Nobutake Tanaka, Hideki Takami, Daisuke Kobayashi, Masahiko Koike, Fuminori Sonohara, Daishi Morimoto, Suguru Yamada, Goro Nakayama, Masamichi Hayashi, Yasuhiro Kodera, Mitsuru Tashiro, Yuki Sunagawa, Chie Tanaka, Mitsuro Kanda
Publikováno v:
Hepatology research : the official journal of the Japan Society of HepatologyREFERENCES. 49(11)
Aim This study aimed to assess the clinical utility of preoperative evaluation of liver fibrosis using platelet-albumin-bilirubin (PALBI) grade, Fibrosis-4 index (FIB-4), and aspartate transaminase-to-platelet ratio index (APRI) for hepatocellular ca